Key statistics
As of last trade Satellos Bioscience Inc (0ITA:STU) traded at 0.374, -21.43% below its 52-week high of 0.476, set on Feb 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.376 |
---|---|
High | 0.39 |
Low | 0.372 |
Bid | 0.374 |
Offer | 0.40 |
Previous close | 0.368 |
Average volume | 0.00 |
---|---|
Shares outstanding | 113.15m |
Free float | 99.08m |
P/E (TTM) | -- |
Market cap | 67.06m CAD |
EPS (TTM) | -0.2044 CAD |
Data delayed at least 15 minutes, as of Oct 09 2024.
More ▼
Press releases
- Satellos Demonstrates Treatment of DMD Canines with SAT-3247 Improved Measures of Strength to Near Normal Levels
- Satellos Announces Dosing of First Participant in Phase 1 Clinical Study of SAT-3247
- Satellos Announces Participation in September 2024 Investor Conferences
- Satellos Announces Acceptance of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247
- Satellos Announces Q2 2024 Financial Results and Updated Canine Data
- Satellos Receives Rare Pediatric Disease Designation from the U.S. FDA for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
More ▼